European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency

By Keen Richard   Jodar Esteban   Iolascon Giovanni   Kruse Hans-Peter   Varbanov Alex   Mann Birgit   Gold Deborah T.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2375-2381

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

By Jönsson B.   Ström O.   Eisman J.   Papaioannou A.   Siris E.   Tosteson A.   Kanis J.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 967-982

Springer Publishing Company

Access to resources Recommend Favorite

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden

By Zethraeus N.   Ström O.   Borgström F.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of the treatment and prevention of osteoporosis—a review of the literature and a reference model

By Zethraeus N.   Borgström F.   Ström O.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 9-23

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

By Kanis J.   Borgstrom F.   Johnell O.   Jonsson B.  

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 862-871

Springer Publishing Company

Access to resources Recommend Favorite